Answers are grounded in this paper and cite their sources.
Retrospective cohort study finds higher carbon dioxide levels predict increased acute exacerbations in COPD, suggesting new risk assessment methods.
Purpose: To investigate the predictive value of the equivalent of carbon dioxide at the anaerobic threshold (EqCO 2 @AT) for acute exacerbations (AE) in patients with chronic obstructive pulmonary disease (COPD). Patients and Methods: This retrospective cohort study included 79 patients with COPD who underwent baseline pulmonary function testing and cardiopulmonary exercise testing (CPET). EqCO 2 @AT = 30 was used only as an empirical threshold for descriptive stratification, rather than as an outcome-derived cutoff. Patients were also classified into non-AE and AE groups according to annualized exacerbation frequency. Baseline characteristics, pulmonary function, and CPET parameters were compared between groups. Logistic regression was used to evaluate the association between EqCO 2 @AT and AE risk. Predictive performance was assessed using receiver operating characteristic curves, calibration analysis, decision curve analysis, Kaplan–Meier analysis, and a simplified nomogram. Results: Of the 79 patients, 16 were classified into the low EqCO 2 @AT group and 63 into the high EqCO 2 @AT group. Patients with higher EqCO 2 @AT were older, had lower BMI, greater smoking exposure, lower FEV 1 % predicted and DLCO% predicted, reduced exercise capacity, and higher ventilatory inefficiency parameters. Compared with the non-AE group, the AE group had worse lung function, lower exercise capacity, and higher VE/VCO 2 slope and EqCO 2 @AT. EqCO 2 @AT was associated with AE risk in univariable analysis (OR 1.122, 95% CI 1.027– 1.226, P = 0.011) and remained significant after adjustment for age, BMI, and FEV 1 % predicted (OR 1.269, 95% CI 1.110– 1.450, P < 0.001). The AUC of EqCO 2 @AT alone was 0.739, whereas the combined model achieved an AUC of 0.850. Kaplan–Meier analysis showed significantly lower AE-free survival in the high EqCO 2 @AT group (log-rank P = 0.002). The simplified nomogram provided an individualized visual tool for AE risk estimation. Conclusion: Elevated EqCO 2 @AT is associated with impaired ventilatory efficiency, reduced exercise capacity, and increased AE risk in COPD. A model incorporating EqCO 2 @AT, age, BMI, and FEV 1 % predicted showed good predictive performance and may support individualized AE risk stratification. These findings suggest that CPET-derived ventilatory efficiency parameters may provide clinically useful information beyond conventional pulmonary function assessment, although validation in larger multicenter prospective cohorts is still required.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: